Levosimendan
KB 431/2018
Approved small_molecule active
Quick answer
Levosimendan for Systolic Heart Failure is a Approved program (small_molecule) at COLLEGIUM PHARMACEUTICAL, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- COLLEGIUM PHARMACEUTICAL, INC
- Indication
- Systolic Heart Failure
- Phase
- Approved
- Modality
- small_molecule
- Status
- active